Platform for nutrition personalization based on genetic and personal data
Currently, the range of food products is becoming more and more diverse. At the same time, the number of people with health problems associated with incorrectly selected nutrition, leading to the development of such common diseases as obesity, type 2 diabetes mellitus, as well as diseases of the gastrointestinal tract (celiac disease and lactase deficiency), is increasing. On the other hand, the development of these diseases and the metabolic response on food are genetically determined. The contribution of genetic factors in development of these diseases varies from 40 to 70%, depending on the nature of the disease. Thus, elucidating the genetic causes of these diseases can help identify appropriate preventive and therapeutic interventions, including diet, to prevent the development of diseases or treat them more effectively. The current capabilities of genetic analysis make it possible to identify an individual reaction to certain nutritional components and prevent diseases associated with an imbalance or intolerance to certain nutrients. That's why nutrigenetics and nutrigenomics significantly developed in recent years, and a large number of studies have been conducted to determine the possible interaction between specific types of diet and genotype and to personalize recommendations for dietary disease prevention and intervention. A sufficient number of studies were accumulated indicating the benefits of taking into account genetics when choosing a treatment strategy and preventing excess weight, metabolic and nutritional disorders (including vitamin and mineral deficiency, lactose intolerance, celiac disease etc.). Platform for nutrition personalization based on genetic and personal data can help identify risk groups for these diseases, personalize their prevention and treatment, and increase people's involvement in improving their own health. We have developed a range of genetic panels with systems for interpretation and recommendations based on individual human genetic data. Our developments are based on the latest data from genetic research, clinical trials and gene-environment (including gene-diet) interactions. For genetic analysis, we use modern, highly accurate and high-tech molecular genetic methods: polymerase chain reaction (PCR) and next-generation sequencing (NGS). Personalization and consulting based on personal genetic characteristics will not only contribute to the increased effectiveness of treatment and prevention of metabolic diseases, vitamin deficiencies, etc., but also to increased patient involvement in their own health improvement.
Biotechnology And National Health
Technologies for human health
Implementation to the clinical practice (medical institutions) - from 3 months to 1 year
Our customers are from more than 50 countries worldwide, including: Australia, Austria, Bahrain, Belgium, Bulgaria, Brazil, Great Britain, Hungary, Vietnam, Germany, Greece, Denmark, Egypt, Israel, Indonesia, Ireland, Spain, Italy, Canada, Qatar, Cyprus, China, Latvia, Lithuania, Lebanon, Luxembourg, Malaysia, Malta, Mexico, Monaco, Netherlands, New Zealand, Norway, UAE, Peru, Poland, Portugal, Romania, USA, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, Thailand, Turkey, Finland, France, Croatia, Montenegro, Czech Republic, Switzerland, Sweden, Estonia, South Korea, Japan, Uzbekistan, Tajikistan, Kazakhstan, Kyrgyzstan, Belarus, Georgia, Armenia, Azerbaijan.
- We have our own genetic testing laboratory. - We have qualified and experienced staff. - We have patents for a method for personalizing diet based on genetics, method of identifying subtypes of diabetes mellitus based on genetics, computer programs. - We created our own test systems, which have low cost for one person. - We obtained a permission to use an unregistered device (reagent kit) for medical purposes. - We have a staff of doctors who participate in the development of recommendations and provide consultations based on the results of genetic testing. - We are basing in Novosibirsk Science Center (Akademgorodok) which is the largest scientific and technical personnel base in Russia.
Winners: “100 best enterprises and organizations of Russia in the field of healthy lifestyle and active longevity” in the category “Best innovative project” (2017). The Golden Mercury Award in the category “Best Small Enterprise in the Field of Innovation” (2017). International exhibition at Ayman University (Dubai 2021) - the best innovative project in the field of healthcare. The Best Small Enterprise of the Year in Novosibirsk in the category “Science and Innovation” (2022). First place in the category “Exporter of the Year in the Sphere of High Technologies” in the regional competition “Exporter of the Year 2023” among small and medium-sized businesses in the Novosibirsk region.
IP: 2018662390 (Computer program: MyGenetics Platform), 2691145 (Method for generating individual dietary recommendations based on DNA analysis), 2021617950 (Program for assessing genetic predispositions to metabolic changes), W 2022/203533A1. Publications: Constructing a pipeline for genome variant/gene functioning hybrid prioritization: a case study of type II diabetes. BGRS Conference, Novosibirsk, June 2020. DOI: 10.18699/BGRS/SB-2020-022; Kolesnikova I.S., Kholyandra I.S., Kushnarenko V.S., Panteleeva N.V., Gvozdeva L.M., Ermolenko N.A., Polunovsky V.V. Genetic testing as a tool for the prevention and treatment of obesity. Therapist's Bulletin. 2023. № 3 (58).
